Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions
2006 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions
Merkler, D.; Schmelting, B.; Czeh, B.; Fuchs, E.; Stadelmann, C. & Brueck, W. (2006)
MULTIPLE SCLEROSIS, 12(4) pp. 369-374. DOI: https://doi.org/10.1191/1352458506ms1290oa
Documents & Media
Details
- Authors
- Merkler, Doron; Schmelting, Barthel; Czeh, Boldizsar; Fuchs, E.; Stadelmann, Christine ; Brueck, Wolfgang
- Abstract
- Pathomorphological studies described pathological heterogeneity in patients with multiple sclerosis (MS). Different effector mechanisms might therefore be responsible for lesion formation in MS. The present report shows that myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) in common marmoset monkeys reflects one specific lesional subtype of MS, namely MS pattern 11 lesions with antibody/complement-mediated damage. MOG-induced EAE in marmoset monkeys will, therefore, provide an ideal model for therapeutic approaches directed against B-cell/antibody/complement in MS.
- Issue Date
- 2006
- Status
- published
- Publisher
- Sage Publications Ltd
- Journal
- MULTIPLE SCLEROSIS
- ISSN
- 1352-4585
